Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jane McElveen"'
Autor:
Christopher Welberry, Isabel Macdonald, Jane McElveen, Celine Parsy-Kowalska, Jared Allen, Graham Healey, William Irving, Andrea Murray, Caroline Chapman
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0232247 (2020)
BackgroundHepatocellular carcinoma (HCC) continues to be a leading challenge in modern oncology. Early detection via blood-based screening tests has the potential to cause a stage-shift at diagnosis and improve clinical outcomes. Tumor associated aut
Externí odkaz:
https://doaj.org/article/96fb10f3039a4345a318369e9aa4e016
Autor:
Catrin H Middleton, William Irving, John F R Robertson, Andrea Murray, Celine B Parsy-Kowalska, Isabel K Macdonald, Jane McElveen, Jared Allen, Graham F Healey, Brian J Thomson, Stephen J Ryder, Stefan Holdenrieder, Caroline J Chapman
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e103867 (2014)
BACKGROUND: Individuals with liver disease, and especially those with Hepatitis B or C, are at an increased risk of developing hepatocellular carcinoma (HCC) which is the third most common cause of cancer-related death worldwide. Inadequate screening
Externí odkaz:
https://doaj.org/article/4dca7442513c4446a6c64c6c158599b5
Autor:
Isabel K Macdonald, Andrea Murray, Graham F Healey, Celine B Parsy-Kowalska, Jared Allen, Jane McElveen, Chris Robertson, Herbert F Sewell, Caroline J Chapman, John F R Robertson
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e51002 (2012)
BackgroundThe National Lung Screening Trial showed that CT screening for lung cancer led to a 20% reduction in mortality. However, CT screening has a number of disadvantages including low specificity. A validated autoantibody assay is available comme
Externí odkaz:
https://doaj.org/article/8438960788f54e9abee9c438965f1446
Autor:
Celine B. Parsy-Kowalska, Jane McElveen, Christopher Welberry, Isabel Macdonald, Graham F. Healey, Jared Allen, William L. Irving, Caroline J. Chapman, Andrea Murray
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0232247 (2020)
PLoS ONE
PLoS ONE
BackgroundHepatocellular carcinoma (HCC) continues to be a leading challenge in modern oncology. Early detection via blood-based screening tests has the potential to cause a stage-shift at diagnosis and improve clinical outcomes. Tumor associated aut
Autor:
Stacy Gilbert, Andrea Murray, James R. Jett, Jane McElveen, Peter J. Mazzone, Jared Allen, Caroline J Chapman
Publikováno v:
Journal of Thoracic Oncology. 12:S546
Autor:
Andrea Murray, John F.R. Robertson, Stefan Holdenrieder, Stephen J. Ryder, Caroline J. Chapman, Catrin H. Middleton, Jane McElveen, Jared Allen, Celine B. Parsy-Kowalska, Brian J. Thomson, Graham F. Healey, Isabel Macdonald, William L. Irving
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 8, p e103867 (2014)
PLoS ONE, Vol 9, Iss 8, p e103867 (2014)
Background Individuals with liver disease, and especially those with Hepatitis B or C, are at an increased risk of developing hepatocellular carcinoma (HCC) which is the third most common cause of cancer-related death worldwide. Inadequate screening
Autor:
Sarah J. Storr, John F.R. Robertson, Andrea Murray, Laura Bottomley, Jane McElveen, Caroline J. Chapman, Celine B. Parsy-Kowalska
Publikováno v:
C35. INSIGHTS INTO LUNG DISEASE USING NOVEL METHODS.
Autor:
Jane McElveen, Özlem Türeci, Rainer Wiewrodt, Anthony Barnes, Caroline J. Chapman, Ugur Sahin, John F.R. Robertson, Ulrich Luxemburger, Andrea Murray
Publikováno v:
Thorax. 63(3)
Background: People with lung cancer usually present at a late stage in the course of their disease when their chances of long-term survival are low. At present there is little to offer for early diagnosis, even in those at high risk of developing the
Publikováno v:
Journal of reproductive immunology. 37(2)
Type I interferons have a variety of important immunological functions, including effects on expression of class I molecules of the major histocompatibility complex (MHC). Interferon-tau (IFN-tau) is an important anti-luteolytic factor produced by th
Autor:
Andrea Murray, Jane McElveen, Caroline J. Chapman, Chris Robertson, John F.R. Robertson, Celine B. Parsy-Kowalska, Isabel K. Macdonald, Graham F. Healey, Jared Allen, Herbert F. Sewell
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 12, p e51002 (2012)
PLoS ONE, Vol 7, Iss 12, p e51002 (2012)
BackgroundThe National Lung Screening Trial showed that CT screening for lung cancer led to a 20% reduction in mortality. However, CT screening has a number of disadvantages including low specificity. A validated autoantibody assay is available comme